These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. ABCB4 disease: Many faces of one gene deficiency. Sticova E; Jirsa M Ann Hepatol; 2020; 19(2):126-133. PubMed ID: 31759867 [TBL] [Abstract][Full Text] [Related]
6. Effect of drug transporter pharmacogenetics on cholestasis. Dietrich CG; Geier A Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1533-51. PubMed ID: 25260651 [TBL] [Abstract][Full Text] [Related]
7. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System. Nakanishi Y; Saxena R Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426 [TBL] [Abstract][Full Text] [Related]
8. Liver transplantation in chronic cholestatic conditions. Milkiewicz P; Wunsch E; Elias E Front Biosci (Landmark Ed); 2012 Jan; 17(3):959-69. PubMed ID: 22201783 [TBL] [Abstract][Full Text] [Related]
9. The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease. Luketic VA; Sanyal AJ Gastroenterologist; 1994 Mar; 2(1):74-9. PubMed ID: 8055235 [TBL] [Abstract][Full Text] [Related]
10. Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis. Stieger B; Geier A Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):411-25. PubMed ID: 21320040 [TBL] [Abstract][Full Text] [Related]
11. Rodent models of cholestatic liver disease: A practical guide for translational research. Gijbels E; Pieters A; De Muynck K; Vinken M; Devisscher L Liver Int; 2021 Apr; 41(4):656-682. PubMed ID: 33486884 [TBL] [Abstract][Full Text] [Related]